Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Amsterdam
Clinical trial register · Netherlands

Clinical Trials in Amsterdam, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3175 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:17 UTC
3175
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1243 Rotterdam 855 Groningen 601 Nijmegen 565 Utrecht 545
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)125 The Netherlands Cancer Institute69 Amsterdam UMC, location VUmc59 AstraZeneca58 Janssen Research & Development, LLC39 Merck Sharp & Dohme LLC33 Bristol-Myers Squibb22 Boehringer Ingelheim22 Novartis Pharmaceuticals21 Erasmus Medical Center19 Stichting Hemato-Oncologie voor Volwassenen Nederland19 Radboud University Medical Center18 AbbVie17 University Medical Center Groningen17 Eli Lilly and Company17 Sanofi15 Leiden University Medical Center15 European Organisation for Research and Treatment of Cancer - EORTC14 Incyte Corporation14 Daiichi Sankyo13 Genmab13 UMC Utrecht12 Hoffmann-La Roche12 Maastricht University Medical Center12 St. Antonius Hospital10 Show all 379
Site location
Amsterdam1243 Rotterdam855 Groningen601 Nijmegen565 Utrecht545 Maastricht421 Leiden386 Eindhoven209 Arnhem181 Breda173 Nieuwegein151 The Hague121 's-Hertogenbosch120 Tilburg113 Zwolle110 Enschede108 Dordrecht103 Amersfoort96 Leeuwarden87 Alkmaar86 Heerlen65 Delft60 Deventer59 Apeldoorn53 Ede51 Show all 164
All 164 locations
Target enrolment
to

Trials with a site in Amsterdam

1243 of 3175 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Active, closed
Saracatinib Trial TO Prevent FOP
NCT04307953Fibrodysplasia Ossificans Progressiva
Amsterdam UMC, location VUmc
Phase 2
20
Amsterdam
2020-08-05
Recruiting
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
NCT04575935Advanced Ovarian Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Serous Neoplasm
M.D. Anderson Cancer Center
Phase 3
580
Amsterdam
2020-08-05
Active, closed
Genentech, Inc.
Phase 1
498
Amsterdam, Leiden, Maastricht, Utrecht
2020-07-29
Active, closed
AstraZeneca
Phase 3
866
Amsterdam, Breda, Hengelo, Leeuwarden, Rotterdam, Sittard-Geleen
2020-07-24
Recruiting
Maastricht University Medical Center
Observational
549
's-Hertogenbosch, Alkmaar, Amsterdam, Apeldoorn, Arnhem, Beverwijk, Bilthoven, Breda
2020-07-16
Active, closed
AstraZeneca
Phase 3
1,012
Amsterdam, Hilversum, Roosendaal, The Hague, Tilburg, Utrecht
2020-07-13
Active, closed
SELUTION SLR™ 014 In-stent Restenosis
NCT04280029Coronary Restenosis
M.A. Med Alliance S.A.
Not applicable
418
Amsterdam, Utrecht, Groningen
2020-07-06
Recruiting
Registry of Patients That Have Undergone ICA or PCI
NCT04815928Coronary Artery Disease
Amsterdam UMC, location VUmc
Observational
10,000
Amsterdam
2020-07-01
Active, closed
Actelion
Phase 3
935
Amsterdam, Nieuwegein, Nijmegen, Rotterdam
2020-06-30
Active, closed
Eli Lilly and Company
Phase 3
996
Tilburg, Amsterdam
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,736
's-Hertogenbosch, Amsterdam, Zwolle, Leeuwarden
2020-06-19
Active, closed
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
NCT04295811Barrett Esophagus, Esophageal Adenocarcinoma, Barretts Esophagus With Dysplasia, Barrett's Esophagus Without Dysplasia
Lucid Diagnostics, Inc.
Not applicable
784
Amsterdam, Eindhoven, Groningen, Nieuwegein, Nijmegen, Rotterdam
2020-06-18
Recruiting
Doxapram Therapy in Preterm Infants (DOXA Trial)
NCT04430790Apnea of Prematurity, Respiratory Insufficiency
DrugDoxapram
Erasmus Medical Center
Phase 3
396
Nijmegen, Maastricht, Veldhoven, Amsterdam, Zwolle, Leiden, Rotterdam, Groningen
2020-06-15
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Amsterdam, Groningen, Rotterdam, Utrecht
2020-06-12
Active, closed
AstraZeneca
Phase 2
452
Amsterdam, Utrecht
2020-06-03
Recruiting
Non Fusion Surgery in Adolescent Idiopathic Scoliosis Patients
NCT04441411Adolescent Idiopathic Scoliosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
18
Amsterdam
2020-06-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Amsterdam, Rotterdam
2020-05-19
Active, closed
ANEUFIX for Endoleak Type II Repair
NCT03918460Abdominal Aortic Aneurysm, Endoleak
TripleMed B.V.
Not applicable
40
Almelo, Amsterdam, Arnhem, Haarlem, Tilburg
2020-05-13
Recruiting
EORTC Metastatic Breast Cancer Module Development
NCT07806266Metastatic Beast Cancer
University of Leeds
Observational
568
Amsterdam
2020-05-01
Active, closed
First in Men Study: BIOMAG-I
NCT04157153Coronary Artery Disease
Biotronik AG
Not applicable
116
Amsterdam
2020-04-27
Active, closed
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
NCT04045717Prostate Adenocarcinoma, Prostate Cancer, Prostate Neoplasm
Universitaire Ziekenhuizen KU Leuven
Phase 2
124
Amsterdam, Nijmegen
2020-04-10
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Amsterdam, Amsterdam, Noord-Holland, Leeuwarden, Nieuwegein, Rotterdam, Utrecht
2020-03-30
Active, closed
University Medical Center Groningen
Phase 3
280
Arnhem, Nijmegen, Maastricht, Eindhoven, Amsterdam, Deventer, Zwolle, Leeuwarden
2020-03-19
Recruiting
UMC Utrecht
Not applicable
1,320
's-Hertogenbosch, Alkmaar, Almelo, Almere Stad, Amersfoort, Amsterdam, Arnhem, Breda
2020-03-05
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Nijmegen, Maastricht, Eindhoven, Tilburg, Amsterdam, Breda, Enschede, Groningen
2020-03-01
Active, closed
Immunocore Ltd
Phase 1/2
410
Amsterdam, Groningen, Leiden
2020-02-25
Active, closed
Janssen Research & Development, LLC
Phase 1
290
Amsterdam, Leiden
2020-02-21
Active, closed
The Netherlands Cancer Institute
Phase 2
52
Amsterdam
2020-02-21
Active, closed
Eli Lilly and Company
Phase 3
261
Harderwijk, 's-Hertogenbosch, Rotterdam, Amsterdam
2020-02-17
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Maastricht, Amsterdam, Leiden, Groningen
2020-02-11
Recruiting
A.J.M. van den Eertwegh
Phase 2
214
Amsterdam
2020-01-22
Recruiting
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
NCT04073290Hepatic Encephalopathy, Cirrhosis, Liver, Portal Hypertension, Liver Diseases
DrugsLactulose·Rifaximin
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 4
238
Amsterdam, Groningen, Leiden, Nijmegen, Rotterdam
2020-01-21
Active, closed
BeOne Medicines
Phase 3
955
Amsterdam, Nijmegen, Utrecht
2020-01-16
Recruiting
The Netherlands Cancer Institute
Phase 2
12
Amsterdam
2020-01-16
Recruiting
The Netherlands Cancer Institute
Phase 2
51
Amsterdam
2020-01-14
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Amsterdam, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam
2020-01-01
Active, closed
USWM CT, LLC
Phase 2
103
Amsterdam
2019-12-31
Recruiting
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
NCT07511933Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Metastases From Melanoma, Brain Metastases From Breast Cancer
The Netherlands Cancer Institute
Not applicable
100
Amsterdam
2019-12-24
Active, closed
University of Roma La Sapienza
Observational
138
Amsterdam
2019-12-20
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Eindhoven
2019-12-20
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Amsterdam, Arnhem, Enschede, Groningen, Nieuwegein, Rotterdam, Utrecht
2019-12-17
Active, closed
The SONImage Study
NCT04125277Breast Cancer
The Netherlands Cancer Institute
Not applicable
100
Amsterdam
2019-12-05
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
140
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Doetinchem, Dordrecht
2019-12-05
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Amsterdam, Groningen
2019-11-07
Active, closed
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT04036682Non Small Cell Lung Cancer, EGFR Exon 20 Mutation
DrugZipalertinib
Cullinan Therapeutics Inc.
Phase 1/2
284
Amsterdam, Leiden
2019-10-31
By invitation
Rigel Pharmaceuticals
Phase 3
90
Amsterdam
2019-10-30
Active, closed
The Netherlands Cancer Institute
Phase 2
38
Amsterdam
2019-10-22
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
Amsterdam
2019-10-09
Recruiting
The Netherlands Cancer Institute
Phase 2
80
Amsterdam
2019-10-04
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Amsterdam
2019-10-03
Active, closed
University of Zurich
Observational
540
Amsterdam
2019-10-01
Active, closed
NeuroDerm Ltd.
Phase 3
381
Amsterdam
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Amsterdam, Dordrecht, Nijmegen
2019-09-26
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
170
Amsterdam, Maastricht, Nieuwegein
2019-09-25
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Amsterdam
2019-09-23
Active, closed
PDC*line Pharma SAS
Phase 1/2
73
's-Hertogenbosch, Amsterdam, Leiden
2019-09-10
Active, closed
Nyxoah S.A.
Not applicable
110
Amsterdam
2019-09-01
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2
49
Nijmegen, Rotterdam, Amsterdam
2019-09-01
Recruiting
Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
NCT04772768Recurrent Angina After Coronary Artery Bypass Graft, Graft Failure, Coronary Artery Disease Progression
Amsterdam UMC, location VUmc
Observational
500
Amsterdam
2019-08-23
Active, closed
Sanofi
Observational
1,860
Amsterdam, Groningen, Rotterdam, The Hague, Utrecht
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Amsterdam, Maastricht
2019-08-15
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Amsterdam
2019-08-12
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Amsterdam, Rotterdam
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Amsterdam, Utrecht
2019-08-05
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1/2
47
Amsterdam
2019-08-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
150
Amsterdam, Deventer, Groningen, Leeuwarden, Leidschendam, Nijmegen, Rotterdam
2019-08-01
Active, closed
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
NCT03797196Renal Transplant Recipients, Elderly Patients, Immunosuppression
DrugsTacrolimus·Everolimus
University Medical Center Groningen
Phase 4
374
Amsterdam, Groningen, Leiden, Nijmegen, Rotterdam, Utrecht
2019-07-29
Active, closed
Novartis Pharmaceuticals
Phase 3
253
Amsterdam, Rotterdam, The Hague
2019-07-26
Active, closed
The Netherlands Cancer Institute
Not applicable
90
Amsterdam
2019-07-22
Active, closed
Tesaro, Inc.
Phase 3
785
Amsterdam, Eindhoven, Enschede, Groningen, Maastricht, Rotterdam
2019-07-18
Active, closed
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases, Urologic Diseases
DrugDcr-Phxc
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 3
75
Amsterdam
2019-07-09
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
48
Amsterdam
2019-07-01
Active, closed
Exelixis
Phase 3
855
Amsterdam, Rotterdam
2019-06-25
Active, closed
AstraZeneca
Phase 2
247
Amsterdam, Maastricht, Nijmegen, Rotterdam
2019-06-25
Active, closed
remedē System Therapy Study
NCT03884660Central Sleep Apnea
Respicardia, Inc.
Observational
225
Amsterdam, Breda, Enschede
2019-06-18
Active, closed
Borstkanker Onderzoek Groep
Phase 2
100
's-Hertogenbosch, Almelo, Amstelveen, Amsterdam, Apeldoorn, Breda, Delft, Deventer
2019-06-15
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Amsterdam, Eindhoven, Nieuwegein, Nijmegen
2019-06-11
Active, closed
Nuvaira, Inc.
Not applicable
464
Amsterdam, Groningen
2019-05-23
By invitation
Prospective Registry on Intravascular Lithotripsy
NCT06577038Calcific Coronary Arteriosclerosis
Leiden University Medical Center
Observational
1,000
Amsterdam, Leiden, 's-Hertogenbosch, Arnhem, Leeuwarden, Nijmegen
2019-05-01
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2
320
's-Hertogenbosch, Almelo, Almere Stad, Amersfoort, Amsterdam, Arnhem, Breda, Delft
2019-05-01
Active, closed
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
NCT03913143Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Vision Disorders
DrugSepofarsen
ProQR Therapeutics
Phase 2/3
36
Amsterdam, Rotterdam
2019-04-04
Recruiting
Vastra Gotaland Region
Phase 1/2
74
Amsterdam, Groningen, Rotterdam
2019-04-01
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Amsterdam, Rotterdam
2019-03-20
Active, closed
Intra-operative Pancreatoscopy in Patients With IPMN
NCT03729453Intraductal Papillary Mucinous Neoplasm
Boston Scientific Corporation
Observational
100
Amsterdam
2019-03-20
Active, closed
AstraZeneca
Phase 3
724
Amsterdam, Groningen, Utrecht
2019-03-06
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
's-Hertogenbosch, Amersfoort, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Eindhoven
2019-03-01
Recruiting
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895Esophageal Neoplasms, Lymph Node Metastases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
5,000
Almelo, Amsterdam
2019-03-01
Active, closed
Borstkanker Onderzoek Groep
Phase 2
462
's-Hertogenbosch, Alkmaar, Almelo, Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Arnhem
2019-02-27
Active, closed
Acerta Pharma BV
Phase 3
984
's-Hertogenbosch, Almere Stad, Amsterdam, Arnhem, Breda
2019-02-25
Active, closed
David Palma
Phase 3
204
Amsterdam
2019-02-22
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Amsterdam, Groningen, Leiden
2019-02-08
Recruiting
The Netherlands Cancer Institute
Not applicable
50
Amsterdam
2019-02-05
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT04075305Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer
UMC Utrecht
Observational
8,000
Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
2019-02-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Amsterdam, Groningen, Leidschendam, Nieuwegein, Nijmegen, Rotterdam, Sittard-Geleen
2019-01-25
Active, closed
Amsterdam UMC, location VUmc
Not applicable
221
Amsterdam, Breda, Eindhoven, Leeuwarden, Nieuwegein, Nijmegen, Utrecht
2019-01-22
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
DrugsCCNU·Lomustine·Abraxane·Adriamycin
Actuate Therapeutics Inc.
Phase 2
350
Amsterdam
2019-01-04
Active, closed
Celgene
Phase 3
363
Amsterdam, Nijmegen, Rotterdam, Sittard-Geleen, The Hague
2019-01-02
Recruiting
JointResearch
Not applicable
75
Amsterdam
2019-01-01
Recruiting
JointResearch
Not applicable
1,100
Amsterdam
2019-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Sittard-Geleen, Amsterdam, Rotterdam
2018-12-28
Recruiting
Vall d'Hebron Institute of Oncology
Phase 2
1,000
Amsterdam
2018-12-10
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Amsterdam
2018-12-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
58
's-Hertogenbosch, Amsterdam, Hoofddorp, Leeuwarden, Nijmegen, Rotterdam, Sittard, Utrecht
2018-11-19
Active, closed
AstraZeneca
Phase 3
1,063
Amsterdam, Breda, Rotterdam
2018-11-16
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Amsterdam
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Amsterdam, Zwolle
2018-10-29
Active, closed
Tesaro, Inc.
Phase 3
1,400
Amsterdam, Groningen, Maastricht, Nijmegen, Rotterdam, Utrecht
2018-10-11
Active, closed
AbbVie
Phase 2
270
Harderwijk, Amsterdam, Amersfoort
2018-10-10
Active, closed
Exelixis
Phase 3
187
Amsterdam, Leiden
2018-10-05
Active, closed
AstraZeneca
Phase 3
730
's-Hertogenbosch, Amsterdam, Groningen, Harderwijk, Hengelo
2018-09-27
Active, closed
V-Wave Ltd
Not applicable
605
Nieuwegein, Amsterdam, Rotterdam
2018-09-19
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
109
's-Hertogenbosch, Amersfoort, Amsterdam, Apeldoorn, Breda, Delft, Dordrecht, Ede
2018-08-30
Active, closed
AbbVie
Phase 3
1,242
Tilburg, Amsterdam
2018-08-28
Recruiting
The Hospital for Sick Children
Observational
4,100
Nijmegen, Boxmeer, Amsterdam, Leiden, Rotterdam, Groningen, Utrecht
2018-08-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Nijmegen, Amsterdam, Rotterdam, Groningen
2018-08-21
Active, closed
AbbVie
Phase 3
1,533
Rotterdam, Amsterdam, Groningen, Utrecht
2018-08-09
Active, closed
Norwegian University of Science and Technology
Phase 2
212
Amsterdam, Arnhem, Breda, Enschede, Rotterdam, Sittard, Utrecht, Zwolle
2018-07-31
Recruiting
Celgene
Phase 2/3
1,541
Amsterdam, Rotterdam, Utrecht
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amsterdam, Tilburg, Uden, Utrecht
2018-07-18
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Amsterdam, Maastricht, Rotterdam, Utrecht
2018-06-26
Active, closed
Memorial Sloan Kettering Cancer Center
Phase 3
732
Amsterdam, Alkmaar, Almelo, Breda, Deventer, Hilversum, Nijmegen, Rotterdam
2018-06-19
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3
554
Amsterdam
2018-06-19
Recruiting
University of Leipzig
Not applicable
120
Amsterdam, Rotterdam
2018-06-18
Active, closed
Exelixis
Phase 3
837
Maastricht, Amsterdam, Rotterdam, Utrecht
2018-06-10
Active, closed
Genentech, Inc.
Phase 1
123
Amsterdam
2018-06-06
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
71
Amersfoort, Amsterdam, Enschede, Groningen, Leiden, Maastricht, Nieuwegein, Rotterdam
2018-06-04
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
61
Amsterdam, Groningen, Maastricht, Nijmegen, Rotterdam, Utrecht
2018-06-04
By invitation
Helsinki University Central Hospital
Observational
200
Amsterdam
2018-06-01
Active, closed
AstraZeneca
Phase 3
1,018
Amsterdam, Breda, Utrecht
2018-05-14
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Genmab
Phase 1/2
560
Amsterdam, Nijmegen, Utrecht
2018-05-02
Active, closed
Longitudinal Early-onset Alzheimer's Disease Study Protocol
NCT03507257Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment
DrugsFlorbetaben·Fluorodeoxyglucose
Indiana University
Observational
850
Amsterdam
2018-04-30
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Amsterdam, Groningen
2018-04-26
Active, closed
MedImmune LLC
Phase 1
400
Amsterdam
2018-04-24
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Almere Stad, Amsterdam, Delft, Dordrecht, Eindhoven, Hoofddorp, Sittard-Geleen, Sneek
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Amsterdam, Maastricht, Sittard-Geleen, Utrecht
2018-04-13
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
55
Amsterdam, Maastricht, Rotterdam
2018-04-11
By invitation
USWM CT, LLC
Phase 1
250
Amsterdam
2018-04-09
Active, closed
AbbVie
Phase 3
1,336
Tilburg, Amsterdam
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Amsterdam, Nieuwegein, The Hague
2018-03-23
Active, closed
Haukeland University Hospital
Phase 3
100
Amsterdam
2018-03-21
Active, closed
AbbVie
Phase 3
747
Nijmegen, Heerlen, Amsterdam, Enschede
2018-03-21
Recruiting
Gene Therapy for Severe Crigler Najjar Syndrome
NCT03466463Crigler-Najjar Syndrome
Genethon
Not applicable
17
Amsterdam
2018-03-19
Active, closed
The Netherlands Cancer Institute
Phase 2
20
Amsterdam, Eindhoven
2018-03-07
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3
389
Almere Stad, Amsterdam, Eindhoven, Groningen, Nieuwegein, Nijmegen, Utrecht
2018-03-01
Recruiting
Leiden University Medical Center
Phase 4
120
Amsterdam, Enschede, Leiden, Rotterdam, The Hague
2018-02-01
Active, closed
Amgen
Phase 1
269
Amsterdam, Maastricht
2017-12-26
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Amsterdam, Utrecht
2017-12-16
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Amsterdam
2017-12-16
Active, closed
Borstkanker Onderzoek Groep
Phase 3
1,050
's-Hertogenbosch, Alkmaar, Almelo, Almere Stad, Amersfoort, Amstelveen, Amsterdam, Apeldoorn
2017-11-09
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
500
Amsterdam
2017-11-01
Active, closed
Maastricht University Medical Center
Not applicable
250
Amsterdam, Maastricht
2017-11-01
Active, closed
Daiichi Sankyo
Phase 1
312
Amsterdam
2017-10-30
Active, closed
The Netherlands Cancer Institute
Phase 3
102
Amsterdam
2017-10-01
Active, closed
Hoffmann-La Roche
Phase 3
382
Amsterdam
2017-09-20
Recruiting
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
NCT03222635Submucosal Esophageal Adenocarcinoma, Barrett Esophagus, High-risk Mucosal Esophageal Adenocarcinoma
Amsterdam UMC
Not applicable
225
Amsterdam, Eindhoven, Groningen, Nieuwegein, Nijmegen, Rotterdam, The Hague, Zwolle
2017-07-25
Active, closed
Eli Lilly and Company
Phase 3
5,637
Maastricht, Amsterdam, Dordrecht, The Hague
2017-07-12
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Alkmaar, Amsterdam, Nieuwegein
2017-07-05
Active, closed
Potassium Supplementation in CKD
NCT03253172Renal Insufficiency, Chronic, Potassium Depletion, Hypertension, Hyperkalemia
Erasmus Medical Center
Not applicable
532
Amsterdam, Groningen, Leiden, Rotterdam
2017-07-01
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Amsterdam, Nijmegen
2017-06-26
Active, closed
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
NCT02758951Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant, Colorectal Carcinoma
Koen Rovers
Phase 2/3
358
Amsterdam, Eindhoven, Groningen, Nieuwegein, Nijmegen, Rotterdam, Utrecht
2017-06-01
Recruiting
University Hospital, Gasthuisberg
Observational
2,000
Amsterdam
2017-05-23
Active, closed
Janssen Research & Development, LLC
Phase 1
302
Amsterdam
2017-05-16
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Amsterdam, Groningen, Maastricht, Nijmegen
2017-05-03
Recruiting
The Netherlands Cancer Institute
Phase 2
353
Amsterdam, Eindhoven, Haarlem, Hilversum, The Hague
2017-03-29
Active, closed
AstraZeneca
Phase 3
987
Amsterdam, Arnhem, Groningen, Hengelo, Maastricht, Rotterdam
2017-03-27
Recruiting
Italian Sarcoma Group
Not applicable
100
Amsterdam, Leiden
2017-03-16
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Amsterdam, Groningen
2017-03-07
Active, closed
The Netherlands Cancer Institute
Not applicable
2,500
's-Hertogenbosch, Alkmaar, Almere Stad, Amsterdam, Arnhem, Assen, Beverwijk, Bilthoven
2017-02-13
Active, closed
ITM Solucin GmbH
Phase 3
324
Amsterdam
2017-02-02
Active, closed
AbbVie
Phase 3
950
Nijmegen, Amsterdam, Leiden, Rotterdam, Utrecht
2017-01-31
Active, closed
The Netherlands Cancer Institute
Phase 3
174
Enschede, Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
2017-01-25
Recruiting
HoFH, the International Clinical Collaborators Registry
NCT04815005Homozygous Familial Hypercholesterolemia
University of Pennsylvania
Observational
1,000
Amsterdam
2017-01-24
Active, closed
IRCCS San Raffaele
Observational
1,402
Amsterdam
2017-01-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Amsterdam, Den Helder, Maastricht, Rotterdam
2016-12-22
Recruiting
ORthosis vs No Orthosis After Surgically Treated Traumatic Thoracolumbar Fractures
NCT03097081Spine Fracture, Orthosis, Traumatic Fracture, Posterior Fixation
Amsterdam UMC, location VUmc
Not applicable
45
Amsterdam
2016-11
Active, closed
ViiV Healthcare
Phase 3
631
Amsterdam, Groningen, Rotterdam, Utrecht
2016-10-27
Active, closed
Celgene
Phase 1/2
466
Amsterdam, Maastrich, Rotterdam, Utrecht
2016-10-14
Active, closed
Eisai Inc.
Phase 3
1,069
Amsterdam, Utrecht
2016-10-13
Recruiting
UMC Utrecht
Observational
500
Amsterdam, Breda, Enschede, Leiden, Maastricht, Utrecht
2016-10
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Amsterdam, Groningen
2016-09-13
Active, closed
European LeukemiaNet
Phase 2
75
Amsterdam
2016-09
Recruiting
The Netherlands Cancer Institute
Phase 2
1,550
Alkmaar, Almelo, Amersfoort, Amsterdam, Apeldoorn, Arnhem, Breda, Delft
2016-08
Active, closed
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674Endometrial Cancer Stage I, Endometrial Cancer Stage II
Leiden University Medical Center
Phase 3
550
Amsterdam, Arnhem, Eindhoven, Flushing, Groningen, Leeuwarden, Leiden, Maastricht
2016-06-10
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Amsterdam, Maastricht
2016-06
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia
DrugsConvalescent plasma·Repagermanium·Ivermectin·Captopril
UMC Utrecht
Phase 3
20,000
Utrecht, 's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Deventer, Ede
2016-04-11
Active, closed
AstraZeneca
Phase 1/2
264
Amsterdam, Maastricht, Nijmegen, Rotterdam, Utrecht
2016-03-17
Active, closed
Geron Corporation
Phase 2/3
289
Nijmegen, Amersfoort, Amsterdam, Groningen
2016-01-12
Recruiting
Mobility and Activity of Daily Living Outcomes After a Hip Fracture.
NCT07556263Hip Fractures (ICD-10 72.01-72.2)
JointResearch
Observational
1,200
Amsterdam
2016-01-01
Active, closed
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
NCT02632708Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), AML Arising From Antecedent Hematologic Disorder (AHD)
DrugsEnasidenib·Mitoxantrone·Idarubicin·Ivosidenib
Institut de Recherches Internationales Servier
Phase 1
153
Amsterdam, Rotterdam
2015-12-31
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Alkmaar, Amsterdam, Nijmegen, Rotterdam, The Hague
2015-11-19
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Amsterdam, Utrecht
2015-11-02
Active, closed
AstraZeneca
Phase 3
1,126
Amsterdam, Breda, Enschede, Groningen, Leiden, Maastricht, Nijmegen
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
Amsterdam, Arnhem, Hoofddorp, Zwolle
2015-10-21
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Amsterdam, Groningen, Nijmegen
2015-08-06
Recruiting
Netherlands Cohort Study on Acute HIV Infection
NCT05728996Acute HIV Infection
Prof. Jan Prins
Observational
183
Amsterdam
2015-08-01
Active, closed
Acerta Pharma BV
Phase 3
533
Almere Stad, Amsterdam, Blaricum, Breda, Delft, Dordrecht, Geleen, Groningen
2015-07-28
Active, closed
AstraZeneca
Phase 3
1,118
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Groningen, Maastricht, Rotterdam
2015-07-21
Active, closed
Medtronic
Observational
3,100
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nieuwegein
2015-07
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Amsterdam
2015-05-01
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Amsterdam, Nijmegen, The Hague
2015-05-01
Active, closed
Acerta Pharma BV
Phase 2
124
Amsterdam, Maastricht, Rotterdam
2015-03-02
Active, closed
Exelixis
Phase 4
247
Amsterdam, Leiden, Groningen
2015-02-25
Active, closed
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers
NCT02321228BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer
University Medical Center Nijmegen
Not applicable
510
Maastricht, Eindhoven, Tilburg, Amsterdam, Leiden, Rotterdam, Groningen, Leeuwarden
2015-01
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
Partner Therapeutics, Inc.
Phase 2
250
Amsterdam, Nijmegen
2015-01
Recruiting
Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"
NCT04776642Arrythmia, Conduction Disorder, Pathophysiology
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
1,000
Amsterdam
2014-12-18
Active, closed
Pfizer
Phase 3
1,068
Amsterdam, Ede, Eindhoven, Groningen, Leeuwarden, Maastricht, Sneek
2014-12-17
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Amsterdam, Amsterdam-Zuidoost, Blaricum, Dordrecht, Groningen, Heerlen, Nieuwegein, Nijmegen
2014-11-26
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Amsterdam, Leiden
2014-11
Active, closed
Acerta Pharma BV
Phase 2
107
Amsterdam, Utrecht
2014-09-11
Active, closed
AbbVie
Observational
1,446
Amsterdam, Rotterdam
2014-08-28
Active, closed
University Medical Center Groningen
Observational
939
Amsterdam, Groningen, Nijmegen
2014-07
Active, closed
AstraZeneca
Phase 3
1,837
Amsterdam, Breda, Geleen, Leiden, Maastricht, Rotterdam, Zaandam
2014-04-22
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Amsterdam, Maastricht, Rotterdam, Utrecht
2014-04
Active, closed
University of Virginia
Observational
2,750
Amsterdam, Rotterdam
2014-04
Active, closed
The Netherlands Cancer Institute
Phase 3
437
's-Hertogenbosch, Alkmaar, Almelo, Amsterdam, Beverwijk, Breda, Delft, Deventer
2013-12-21
Active, closed
AstraZeneca
Phase 3
510
's-Hertogenbosch, Amsterdam, Bergen op Zoom, Maastricht
2013-09-25
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Amsterdam
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Amsterdam, Maastricht, Nijmegen, Rotterdam
2013-09-03
Active, closed
University Medical Center Groningen
Not applicable
217
Amsterdam, Groningen, Nijmegen
2013-08-30
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Amsterdam, Maastricht
2013-08-26
Active, closed
The Netherlands Cancer Institute
Phase 2
304
Alkmaar, Almelo, Amersfoort, Amsterdam, Apeldoorn, Arnhem, Bergen op Zoom, Beverwijk
2013-07
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Amsterdam
2013-05-30
Recruiting
Dutch Colorectal Cancer Group
Observational
50,000
's-Hertogenbosch, Alkmaar, Almere Stad, Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Arnhem
2013-05
Active, closed
Radboud University Medical Center
Not applicable
478
's-Hertogenbosch, Alkmaar, Almelo, Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Breda
2013-05
Active, closed
Washington University School of Medicine
Phase 2/3
490
Amsterdam
2012-12
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Amsterdam, Doetinchem, Eindhoven, Enschede, Groningen, Hengelo, Leiden, Maastricht
2012-01
Active, closed
University Medical Center Groningen
Phase 3
920
Groningen, Alkmaar, Amsterdam, Assen, Breda, Delft, Deventer, Eindhoven
2011-06-21
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Amsterdam
2010-12
Active, closed
Comorbidity and Aging With HIV
NCT01466582HIV-1-infection, Comorbidity, Ageing
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
1,148
Amsterdam
2010-10
Recruiting
A European Network for the Investigation of Gender Incongruence
NCT01072825Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
DrugBlood sampling
University Hospital, Ghent
Observational
125
Amsterdam
2010-02-15
Active, closed
AstraZeneca
Phase 2
162
Amsterdam, Nijmegen, Rotterdam
2010-02-04
Active, closed
The Netherlands Cancer Institute
Phase 2/3
310
Alkmaar, Amsterdam, Delft, Deventer, Dordrecht, Ede, Haarlem, Heerlen
2010-01
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
305
Amsterdam, Groningen, Maastricht, Rotterdam
2009-09
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Amsterdam, Rotterdam
2009-07
Recruiting
Radboud University Medical Center
Observational
176
Amsterdam, Nijmegen, Rotterdam, Tilburg
2009-02
Recruiting
Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817Alzheimer's Disease
Washington University School of Medicine
Observational
700
Amsterdam
2009-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Amsterdam, Groningen, Maastricht, Nijmegen, Rotterdam, The Hague
2007-12
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Amsterdam
2001-07-31
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Blaricum, Breda, Brunssum, Delft
1998-10
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Amsterdam
1994-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Amsterdam
1991-04-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
's-Gravenhage (Den Haag, the Hague), 's-Hertogenbosch, Alkmaar, Amsterdam, Blaricum, Eindhoven, Enschede, Heerlen
1989-09
Recruiting
Medtronic
Observational
20,000
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nieuwegein
1983-01
Rows per page Showing 1001–1243 of 1243
Previous 1 2 3
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/amsterdam?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,175 studies in total at the last sync on 13 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,243 of those studies with a site in Amsterdam.

How many clinical trials are recruiting in Amsterdam?

687 of the 1,243 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:17 UTC sync. A further 52 have not yet opened recruitment, 472 are active but closed to new participants, and 32 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.